Skip to main content

TPOXX News

SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX (tecovirimat)

NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) – SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the ...

FDA Approves TPOXX (tecovirimat) as the First Drug for the Treatment of Smallpox

July 13, 2018 – The U.S. Food and Drug Administration today approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox. Though the World Health Organization declared...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

TPOXX patient information at Drugs.com